Questions? Call 888-624-8373

HARDBACK + PDF
your price: $58.50
add to cart

HARDBACK
list:$49.95
Web:$44.96
add to cart

PDF BOOK
your price: $38.50
add to cart

PDF CHAPTERS
your price: $3.90
select

Rights & Permissions

topleft topright

Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance (2004)
Board on Global Health (BGH)

Page
356
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance

LICUS. See Low Income Countries Under Stress Initiative

Light microscopy, 220–221

Lincoln, Abraham, 126

Linnaeus, Carl, 130

Liver schizont, 138

Living standards, 174, 182–183

London School of Hygiene and Tropical Medicine, 130

Low Income Countries Under Stress Initiative (LICUS), 103, 105

Lugo, Juan de, 130

Lumefantrine, 62, 253, 255, 258, 294

Lusaka, Zambia, 40, 41, 44

M

Macdonald, G., 144

Macrolides, 309

Madagascar, 96, 97, 98, 146, 207

Magic spells, 30

Malaria

cerebral, 152–151

clinical, 252–253

control, 197–238

cost of illness, 192

current situation, 2–4, 19–21, 23–24, 26–27

economic burden of, 177–194

epidemic, 142–143, 230–231

health burden of, 168–177

historical estimates of costs, 179

history of discoveries, 125–127

immunity, 144–147

in specific areas, 24–26, 25

integrated control of, 11

medicines and supplies service, 120–121

mortality rates, 2, 19, 169, 170, 172–175, 174, 176, 198, 203–205

pathogenicity, 144

recrudescence, 140

recurrent, 140

severe, 256–257

symptoms, 27

transmission, 212–213

treatment. See Treatment

uncomplicated, 254

urban, 230

Malaria early warning systems (MEWS), 232–233

Malaria Medicines and Supplies Service, 120–121

Malaria Vaccine Initiative (MVI), 47

Malarine, 38, 41, 43

Malarone, 65, 253, 294, 306

Malawi

antimalarial drug resistance, 270, 271

chloroquine resistance, 132

drug policy, 235

HIV, malaria, and pregnancy, 157

hospital-based evidence, 176–177

household expenditures on prevention and treatment, 184

indirect costs, 185

IPT, 218

migration, 232

per capita health expenditures, 98

productivity costs of morbidity, 188–189

total direct and indirect costs (of malaria), 186

Malaya, 132

Mali, 43, 271, 280, 318

Malignant tertian malaria. See Plasmodium falciparum

Maloprim, 217

Management Sciences for Health (MSH), 34, 119

Manson, Patrick, 129

Mao Tse Tung, 133

Mapping Malaria Risk in Africa (MARA), 47, 169

Mass drug administration (MDA), 208, 212–213, 216, 233

Mauritius, 179

Mawanhgolui Han dynasty, 133

Mbarara, Uganda, 321

McClellan, George, 126

McGregor, I.A., 216

MDA. See Mass drug administration

MDGs. See Millennium Development Goals

MDR. See Multidrug resistant

Meckel, Johann Friedrich, 128

Médecins Sans Frontières (MSF), 62, 64, 75

Medicines for Malaria Venture (MMV)

antimalarial drugs R&D, 10, 15, 81

major initiatives, 47

partnerships, 48, 74, 76, 302

R&D, 301, 303–305, 304, 307–309

synthetic artemisinin, 64

Mefloquine

analogs, 310

Page
356